Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Assess the PK Profile of NanoBUP Capsules Relative to Suboxone

This study has been completed.
Information provided by (Responsible Party):
Nanotherapeutics, Inc. Identifier:
First received: December 13, 2010
Last updated: April 13, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)